Our Board of Directors

Ayse Kocak – Chief Executive Officer

Ayse Kocak has served as our Chief Executive Officer since February 2013 and has been a member of the Board since February 2012. Prior to joining the Company as Chief Executive Officer, from February 2009 to February 2013, Ms. Kocak started and served as a general manager at moksha8 Pharmaceuticals, Inc. in Mexico, a specialty pharmaceutical company that focuses on therapeutics to treat the central nervous system and mental health disorders. Previously, Ms. Kocak served in various commercial roles with subsidiaries of Pfizer Inc. around the world, including in the United States, Europe, Latin America, Africa and the Middle East, and was involved in the launch and commercialization of Lipitor®, Viagra®, Norvasc® and Geodon®. Ms. Kocak holds a bachelor’s degree from Bosphorous University.

Declan McKeon – Director

Declan McKeon has been a member of the Board since April 2015. Mr. McKeon served as a consultant to PricewaterhouseCoopers (“PwC”) from 2007 to 2015. From 1986 to 2007, Mr. McKeon served as a partner at PwC and held leadership positions on the audit and business advisory teams in Ireland and was an executive of the PwC Europe audit and business advisory services group. Mr. McKeon currently serves on the boards of directors of Icon plc and Ryanair plc. Mr. McKeon holds both a master’s degree in Business and Accounting and a bachelor’s degree from University College Dublin.

Daniel K. Turner III – Chairman

Daniel K. Turner III has been a member of the Board and its Chairman since October 2010. Mr. Turner is the managing director and a general partner at Montreux Equity Partners, a private investment company he founded in 1993. Mr. Turner currently serves on the boards of directors of moksha8 Pharmaceuticals, Inc. and has served on the boards of directors of multiple companies, including Epirus Biopharmaceuticals, Inc., Glaukos Corporation, Orexigen Therapeutics, Inc., Renal CarePartners, Inc., Transcept Pharmaceuticals, Inc. and Tobira Therapeutics, Inc. Mr. Turner holds a bachelor’s degree from California State University, Sacramento.

Michel Rouif, M.D. – Director

Michel Rouif, M.D. has been a member of the Board since April 2015. Dr. Rouif is an aesthetic plastic surgeon in France and has been in private practice since 1994. Dr. Rouif is also a professor at François Rabelais University in Tours and Reneé Descartes University, in Paris, France. Dr. Rouif is Board Certified in France in Plastic, Reconstructive and Aesthetic Surgery and Microsurgery, and has a Diploma of Legal Compensation of Bodily Injuries. Dr. Rouif received a medical degree from René Descartes University, in Paris, France.

William McCabe – Director

William McCabe has been a member of the Board since May 2008. Mr. McCabe is the executive chairman of Oyster Capital Partners, a private investment company he founded in September 2000. Mr. McCabe is also the chief executive officer of Novaerus Limited, a position he has held since September 2013. Mr. McCabe currently serves on the board of directors of Fieldaware Group Limited, Novaerus Group Limited, Novaerus UK Limited and Oyster Technologies Limited and has served on the boards of directors of Datahug Limited and Fleetmatics Group Limited. Mr. McCabe holds a bachelor’s degree from Queens University of Belfast.